PEPENDIUM LABS

Free research / Source-linked guides

Peptide study guides

Find a peptide, see who or what was studied, what was measured, and how the experiment was structured. Human studies and preclinical research are labeled separately.

Start typing to see peptide suggestions. Every name below has a research-search route; a checked source-method guide is available only where labeled.

← Browse all study guides

These guides report individual source methods and findings. They are not standardized or personal-use dosing protocols. A preclinical study does not establish a human regimen; original source records may change.

1 checked guide shown for SS-31. This is a bounded sample, not a complete peptide catalog. Search research on any peptide.

Human study

SS-31

Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction

Evidence sourceTrial registry · NCT02788747
Studied inParticipants with stable heart failure with reduced ejection fraction; 71 enrolled
DesignPhase 2 trial with two active arms and placebo
Human protocolNo general protocol established by this single study

What researchers measured

  • Primary: change in left-ventricular end-systolic volume
  • Secondary: left-ventricular ejection fraction, end-diastolic volume, stroke volume and cardiac output

Methods reported in this human study

4 mg elamipretide
4 mg subcutaneous, once daily for 28 consecutive days
40 mg elamipretide
40 mg subcutaneous, once daily for 28 consecutive days
Placebo
Subcutaneous placebo, once daily for 28 consecutive days

The registry names the intervention elamipretide. SS-31 is a literature alias; molecular form and formulation must be checked at the original source, not inferred from a distributor label.

Source checked 2026-09-28. This snapshot is not automatically updated.

Open original source (NCT02788747) ↗ · Check the SS-31/elamipretide name link ↗

Search all original studies on SS-31 → · Open Mix Chart →

See broader research collection status